# McKesson vs Moderna: valuation, size and margins compared

URL: https://funkfolio.com/compare/mck-vs-mrna

> McKesson and Moderna side by side: market value, valuation, margins, balance sheet, one-year price change and superinvestor holders.

---

## McKesson vs Moderna

McKesson (MCK), health care, and Moderna (MRNA), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

McKesson is worth $126B on the stock market and Moderna $83.7B: McKesson is valued at 51% more. McKesson's operating margin in its latest fiscal year was 1.54% and Moderna's -158%. Over the past year McKesson's share price has moved +28.4% and Moderna's +764%.

### Key facts

- **McKesson market value:** $126B
- **Moderna market value:** $83.7B
- **McKesson P/E:** 28.2
- **McKesson revenue:** $403.4B FY to 2026-03-31
- **Moderna revenue:** $1.9B FY to 2025-12-31
- **Superinvestors holding both:** 0

Market values as of 18 Nov 2026, 06:20 UTC.

McKesson vs Moderna: every measure side by side

| Measure | McKesson | Moderna |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2026-03-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $126B higher | $83.7B lower |
| Revenue | $403.4B higher | $1.9B lower |
| Earnings | $4.8B higher | -$2.8B lower |
| Employees | 41,600 higher | 4,700 lower |
| Total assets | $82.3B higher | $12.3B lower |
| Valuation |  |  |
| P/E | 28.2 | — |
| P/S | 0.3 lower | 43.0 higher |
| P/B | — | 12.2 |
| Dividend yield | 0.31% higher | 0.00% lower |
| Profitability |  |  |
| Operating margin | 1.54% higher | -158% lower |
| Balance sheet |  |  |
| Net assets | -$2.2B lower | $8.7B higher |
| Total liabilities | $83.2B higher | $3.7B lower |
| Total debt | $6.5B higher | $590M lower |
| Cash on hand | $4B higher | $2.6B lower |
| Price change |  |  |
| Today | -1.21% higher | -3.93% lower |
| 1 year | +28.4% lower | +764% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: McKesson 127.6, Moderna 835.2.

- McKesson (MCK)
- Moderna (MRNA)

McKesson and Moderna share prices over one year, rebased to 100: McKesson ends at 127.6, Moderna at 835.2.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | MCK | MRNA |
| --- | --- | --- |
| Nov 28, 2025 | 103.0 | 104.9 |
| Dec 31, 2025 | 95.9 | 119.1 |
| Jan 30, 2026 | 97.2 | 178.0 |
| Feb 27, 2026 | 115.5 | 216.4 |
| Mar 31, 2026 | 101.2 | 205.2 |
| Apr 30, 2026 | 95.3 | 185.5 |
| May 29, 2026 | 86.8 | 190.6 |
| Jun 30, 2026 | 88.4 | 282.8 |
| Jul 31, 2026 | 100.1 | 221.4 |
| Aug 31, 2026 | 103.5 | 566.8 |
| Sep 30, 2026 | 99.8 | 777.7 |
| Oct 30, 2026 | 116.3 | 895.5 |
| Nov 17, 2026 | 127.6 | 835.2 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (0)

None of the tracked investors.

#### McKesson only (13)

- [Ron Muhlenkamp (founder)](https://funkfolio.com/gurus/ron-muhlenkamp) 5.7%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 0.8%
- [Frank Sands](https://funkfolio.com/gurus/frank-sands) 0.6%
- [Paul Tudor Jones](https://funkfolio.com/gurus/paul-tudor-jones) 0.4%
- [Stephen Mandel](https://funkfolio.com/gurus/stephen-mandel) 0.3%
- [Cliff Asness](https://funkfolio.com/gurus/cliff-asness) 0.2%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.2%
- [David Shaw (founder)](https://funkfolio.com/gurus/david-shaw) 0.2%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.2%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.1%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) &lt;0.1%
- [Temasek](https://funkfolio.com/gurus/temasek) &lt;0.1%

#### Moderna only (2)

- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 2.1%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.4%

Percentages are each holding's share of that investor's reported portfolio. [Who owns MCK](https://funkfolio.com/stock/MCK/superinvestors) · [Who owns MRNA](https://funkfolio.com/stock/MRNA/superinvestors)

### More on McKesson

- [McKesson (MCK) stock page](https://funkfolio.com/stock/MCK)
- [McKesson market cap](https://funkfolio.com/stock/MCK/market-cap)
- [McKesson revenue](https://funkfolio.com/stock/MCK/revenue)
- [McKesson P/E ratio](https://funkfolio.com/stock/MCK/pe-ratio)
- [McKesson operating margin](https://funkfolio.com/stock/MCK/operating-margin)
- [McKesson total debt](https://funkfolio.com/stock/MCK/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Moderna

- [Moderna (MRNA) stock page](https://funkfolio.com/stock/MRNA)
- [Moderna market cap](https://funkfolio.com/stock/MRNA/market-cap)
- [Moderna revenue](https://funkfolio.com/stock/MRNA/revenue)
- [Moderna P/E ratio](https://funkfolio.com/stock/MRNA/pe-ratio)
- [Moderna operating margin](https://funkfolio.com/stock/MRNA/operating-margin)
- [Moderna total debt](https://funkfolio.com/stock/MRNA/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### McKesson against its closest peers

- [McKesson vs Stryker](https://funkfolio.com/compare/mck-vs-syk)
- [McKesson vs Bristol-Myers Squibb](https://funkfolio.com/compare/bmy-vs-mck)
- [McKesson vs Sanofi](https://funkfolio.com/compare/mck-vs-sny)
- [McKesson vs Medtronic](https://funkfolio.com/compare/mck-vs-mdt)

#### Moderna against its closest peers

- [Moderna vs CVS Health](https://funkfolio.com/compare/cvs-vs-mrna)
- [Moderna vs Sanofi](https://funkfolio.com/compare/mrna-vs-sny)
- [Moderna vs HCA Healthcare](https://funkfolio.com/compare/hca-vs-mrna)
- [Moderna vs GSK](https://funkfolio.com/compare/gsk-vs-mrna)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, McKesson or Moderna?**

By market value, McKesson is the larger: $126B against $83.7B for Moderna. By revenue in its latest fiscal year, McKesson is the larger: $403.4B against $1.9B for Moderna.

**Which has the higher operating margin?**

McKesson: 1.54%, against -158% for Moderna. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

McKesson: 0.31%, against 0.00% for Moderna. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

McKesson: $6.5B, against $590M for Moderna. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both McKesson and Moderna?**

None of the tracked superinvestors holds both in their latest 13F filing. 13 hold McKesson and 2 hold Moderna.

### Cite this page

Funkfolio, “McKesson vs Moderna”, data as of 18 November 2026. https://funkfolio.com/compare/mck-vs-mrna

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
